NEGRINI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 22.647
EU - Europa 7.118
AS - Asia 5.966
SA - Sud America 394
AF - Africa 30
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 36.176
Nazione #
US - Stati Uniti d'America 22.564
SG - Singapore 2.390
CN - Cina 2.254
IT - Italia 1.572
DE - Germania 1.463
UA - Ucraina 1.334
TR - Turchia 864
GB - Regno Unito 660
FI - Finlandia 559
PL - Polonia 497
SE - Svezia 420
BR - Brasile 352
ID - Indonesia 146
FR - Francia 115
BE - Belgio 111
VN - Vietnam 86
RU - Federazione Russa 82
NL - Olanda 81
CA - Canada 71
HK - Hong Kong 59
AT - Austria 55
CZ - Repubblica Ceca 55
RO - Romania 31
IN - India 30
IR - Iran 28
LT - Lituania 27
AR - Argentina 14
IE - Irlanda 14
IQ - Iraq 12
JP - Giappone 12
KR - Corea 11
PK - Pakistan 11
AU - Australia 9
CH - Svizzera 8
EC - Ecuador 8
EU - Europa 8
JO - Giordania 8
GR - Grecia 7
MA - Marocco 7
AE - Emirati Arabi Uniti 6
UZ - Uzbekistan 6
BD - Bangladesh 5
BO - Bolivia 5
PH - Filippine 5
TN - Tunisia 5
TW - Taiwan 5
ZA - Sudafrica 5
DO - Repubblica Dominicana 4
ES - Italia 4
KZ - Kazakistan 4
PE - Perù 4
BG - Bulgaria 3
CO - Colombia 3
IL - Israele 3
KE - Kenya 3
LV - Lettonia 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GH - Ghana 2
HU - Ungheria 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
CV - Capo Verde 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 36.175
Città #
Fairfield 2.943
Woodbridge 2.756
Houston 1.850
Chandler 1.546
Jacksonville 1.501
Ashburn 1.449
Ann Arbor 1.188
Santa Clara 1.115
Seattle 1.074
Wilmington 1.021
Singapore 994
Cambridge 903
Izmir 561
Warsaw 494
Beijing 476
Nanjing 467
Munich 396
Ferrara 371
Princeton 346
New York 326
San Diego 272
Boardman 243
Helsinki 240
Milan 219
Shanghai 204
Los Angeles 142
Nanchang 140
Jakarta 139
Shenyang 129
Bremen 110
Brussels 104
Dearborn 103
Tianjin 92
Addison 90
Falls Church 87
Dong Ket 81
London 76
Changsha 75
Hebei 71
Jiaxing 68
Jinan 63
Mountain View 61
Bologna 58
San Mateo 55
Hong Kong 54
Kunming 52
Redwood City 48
Rome 46
Brno 45
Washington 45
Norwalk 44
Toronto 43
Nuremberg 40
Ningbo 39
Zhengzhou 39
Guangzhou 38
Falkenstein 37
Auburn Hills 34
Vienna 30
Tappahannock 29
Verona 29
Philadelphia 28
Augusta 27
Frankfurt am Main 27
Hangzhou 26
Orange 26
Des Moines 25
São Paulo 24
Leawood 22
Ottawa 22
Hefei 21
Jyväskylä 20
Turin 19
Indiana 18
Naples 18
Council Bluffs 17
Taizhou 17
Timisoara 17
Lanzhou 16
Napoli 16
Amsterdam 15
Ardabil 15
Changchun 15
Dublin 13
Monmouth Junction 13
Redmond 13
Kilburn 12
Rio de Janeiro 12
Chicago 11
Bari 10
Monte San Pietro 10
Amman 8
Ferrara di Monte Baldo 8
Haikou 8
Lappeenranta 8
Palermo 8
Porto Alegre 8
San Jose 8
Acton 7
Belo Horizonte 7
Totale 26.006
Nome #
Applicazione della tecnica di metilazione specifica PCR (MSP) con un pannel di quattro markers su campioni citologici di patologia mammaria. 561
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 302
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 276
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 242
Absolute quantification of cell-free microRNAs in cancer patients 206
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 203
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 197
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 197
Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers 196
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 191
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 189
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 185
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 182
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 176
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 172
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 171
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 170
Anti-Tumor Activity of a miR-199-dependent Oncolytic Adenovirus 167
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 167
MicroRNA e cancro 166
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 165
N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration 164
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 161
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 157
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer models 157
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 156
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 156
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 155
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 154
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 150
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 150
MicroRNA involvement in hepatocellular carcinoma 149
p53/MDM2 Feed-back Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma 148
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 148
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 146
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 146
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 146
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 146
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 145
Circulating non-coding RNA as biomarkers in colorectal cancer 145
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 145
Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag 144
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 144
Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells 143
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 143
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 143
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 141
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 141
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 140
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 140
Refined subchromosomal location of 21 expressed sequence tags from unknown genes at region 11p15 140
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 139
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 139
RASSF1A QUANTITATIVE METHYLATION-SPECIFIC DROPLET DIGITAL PCR IN URINARY CELLS AS BIOMARKER FOR PROSTATE CANCER DETECTION 138
Combining anti-miR-155 with chemotherapy for the treatment of lung cancers 138
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 136
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 135
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 134
Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes 134
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 134
Regulatory mechanisms of microRNAs involvement in cancer 134
Tumor suppressor functions of ARLTS1 in lung cancers 133
miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma 133
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 133
null 132
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 132
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 132
Detection of DNA mutations in urine of patients with prostate cancer by NGS technology 132
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 130
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 130
Reprogramming of miRNA networks in cancer and leukemia 130
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 130
null 128
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 127
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 127
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 127
Cryptic insertion producing two NUP98/NSD1 chimeric transcripts in adult refractory anemia with an excess of blasts 127
A microRNA signature of hypoxia 127
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 127
MicroRNA response to environmental mutagens in liver 127
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 124
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 124
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 124
Animal Models of Hepatocellular Carcinoma Prevention 124
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 123
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 123
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 123
Simian virus 40 infection in humans and association with human diseases: results and hypotheses 122
Extensive modulation of a set of microRNAs in primary glioblastoma 122
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 122
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 122
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 122
Cloning and characterization of two overlapping genes in a subregion at 6q21 involved in replicative senescence and schizophrenia 121
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 121
MicroRNA deregulation in human thyroid papillary carcinomas 121
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 120
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 120
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 120
microRNAs and cancer – new paradigms in molecular oncology 119
Evidence for BK virus as a human tumor virus 119
Totale 15.185
Categoria #
all - tutte 179.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.323
Totale 187.320


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.170 0 0 0 0 0 0 0 0 0 697 293 180
2020/20214.955 399 436 345 503 209 470 202 510 126 692 701 362
2021/20223.752 139 356 300 169 193 188 217 219 122 271 360 1.218
2022/20233.610 390 233 128 466 604 522 162 301 454 32 189 129
2023/20242.169 187 245 95 58 169 498 112 186 44 42 59 474
2024/20256.188 188 179 650 350 1.005 859 481 499 1.606 371 0 0
Totale 36.697